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Abstract
Fibers of poly(N-isopropylacrylamide) (PNIPAAm), ethylcellulose (EC) and a blend
of both were successfully fabricated by electrospinning. Analogous drug-loaded fibers
were prepared loaded with ketoprofen (KET). Scanning and transmission electron
microscopy showed that the fibers were largely smooth and cylindrical, with no phase
separation observed. The addition of KET to the spinning solutions did not affect the
morphology of the resultant fibers, and no drug particles could be observed to
separate from the polymer matrix. X-ray diffraction demonstrated that the drug was
present in the amorphous physical form in the fiber matrix. There are significant
intermolecular interactions between KET and polymers, as evidenced by IR
spectroscopy and molecular modelling. Water contact angle measurements proved
that the PNIPAAm and PNIPAAm/EC fibers switched from being hydrophilic to
hydrophobic when the temperature was increased through the lower critical solution
temperature of 32 ºC. In vitro drug release studies found that the PNIPAAm/EC blend
nanofibers were able to synergistically combine the properties of the two polymers,
giving temperature-sensitive systems with sustained release properties. In addition,
they were established to be non-toxic and suitable for cell growth. This study thus
demonstrates that electrospun blend PNIPAAm/EC fibers comprise effective and
biocompatible materials for drug delivery systems and tissue engineering.
Keywords: poly(N-isopropylacrylamide), ethylcellulose, electrospinning, controlled
release, temperature-sensitive, biocompatible materials, contact angle, molecular
modelling, morphology, amorphous
1. Introduction
Electrospinning comprises a straightforward and cost-effective technique for the
fabrication of fibers with dimensions on the nanometer to micron scale.1, 2 Electrospun
nanofibers have attracted considerable attention due to their high surface area to
volume ratio, narrow diameters, high porosity and often desirable mechanical
properties.3-8 They are attractive for a number of practical applications, such as wound
dressing, drug delivery, tissue engineering, medical prostheses, textiles, filtration
systems, and sensors, inter alia.9-13
Responsive polymers exhibit a change in configuration, dimensions, or
physicochemical properties following exposure to an external stimulus. This could
comprise changes in pH, temperature, electromagnetic field, light or solvent.14-16
Poly(N-isopropylacrylamide) (PNIPAAm) is one such polymer, and undergoes a
sharp phase transition (from linear to globular) at a lower critical solution temperature
(LCST) of ca. 32 ºC in aqueous solution.17-19 It has been intensively studied for
potential applications in biomedicine.20-22 When the temperature is raised from below
to above the LCST, PNIPAAm rapidly changes from being hydrophilic to
hydrophobic.23, 24
While attractive for its thermoresponsive properties, PNIPAAm cannot easily be
electrospun. Thus, researchers have resorted to the use of copolymers or blends of
PNIPAAm with other polymers to aid the spinning process and enhance the quality of
the fibers produced.25-28 In one such study, Wang and co-workers electrospun blends
of PNIPAAm and polystyrene; the resultant nanofibers exhibited reversible
superhydrophilicity and superhydrophobicity when the temperature was varied
between 20 ºC and 50 ºC.29 Lin et al. explored PNIPAAm /
poly(2-acrylamido-2-methylpropanesulfonic acid) nanofibers, and found that drug
release at temperatures below the LCST was faster than when experiments were
performed above the LCST.30 In other work, Song produced PNIPAAm /
poly(ethylene oxide) (PEO) composite nanofibers.31 The fibers were loaded with
vitamin B12 as a model hydrophilic drug, and the release profile could be modulated
by varying the PEO/PNIPAAm ratio, the release temperature, and the drug loading. In
this work, we aimed to expand on these earlier investigations to develop enhanced
understanding of the properties of electrospun PNIPAAm blends with other polymers.
Ketoprofen (KET), a non-steroidal anti-inflammatory drug, has been widely used
for the treatment of inflammation, pain and rheumatism but suffers from very poor
water solubility (0.5 µg/ml).32 It also has a short biological half-life (1.5 to 2 hours).33
Commercially it is available as a number of formulations, including ketoconazole and
ketolac. The dosing regimen is 50-100 mg twice a day.32 Therefore, it is desirable to
develop controlled release formulations of KET to increase patient convenience and
reduce side effects.
In this study, KET was chosen as a model drug for the development of controlled
release formulations. It was blended with PNIPAAm and ethylcellulose (EC, an inert,
water-insoluble, non-toxic polymer widely used to prepare slow-release formulations)
and electrospun into fibers.34, 35 By combining these three components, we aimed to
produce thermoresponsive sustained release formulations of KET. These could be
used to ensure that the drug concentration in the body remains within the therapeutic
window for prolonged periods of time, mimizing over- or underdosing and
maximizing therapeutic benefit and patient convenience.
2. Experimental
2.1 Materials
N-isopropylacrylamide (NIPAAm) was purchased from Japan TCI (Tokyo, Japan).
Ethyl cellulose (EC, 6-9 m Pa·s) was obtained from the Aladdin Chemistry Co., Ltd.
(Shanghai, China). Ketoprofen (KET) was purchased from the Beijing J&K Scientific
Co., Ltd. (Beijing, China). L929 cells (a mouse fibroblast cell line) were obtained
from the Institute of Biochemistry and Cell Biology (Chinese Academy of Sciences,
Shanghai, China). DMEM medium, thiazolyl blue (MTT reagent), fetal bovine serum
(FBS), phosphate-buffered saline (PBS), penicillin and streptomycin were purchased
from the Nanjing keyGEN Biotechnology Co., Ltd. (Nanjing, China). Tween-80 and
dimethyl sulfoxide (DMSO) were provided by the Sinopharm Chemical Reagent Co.,
Ltd. (Shanghai, China). Acetone was purchased from the Yonghua Chemical
Technology Co., Ltd. (Suzhou, China), while azobisisobutyronitrile (AIBN) was
provided by the Shisi Hewei Chemical Co., Ltd. (Shanghai, China). Anhydrous ether
and anhydrous ethanol were obtained from the Changshu Hongsheng Fine Chemical
Co., Ltd. (Suzhou, China). All chemicals were of analytical grade and used directly
without further purification. Water was deionized prior to use.
2.2 Synthesis of PNIPAAm
A solution of NIPAAm (5.00 g) and AIBN (25.00 mg) in 10 mL of anhydrous ethanol
was degassed and heated to 70 ºC under a positive pressure of N2. After 7 h, the
resultant polymer was precipitated in anhydrous ether. The crude product was then
reprecipitated from 50 mL of acetone into 200 mL of anhydrous ether three times, to
yield 4.20 g (84%) of a pure product. Successful synthesis was verified by IR and
NMR spectroscopies, and gel permeation chromatography (see Supporting
Information).
2.3 Preparation of electrospinning solutions
PNIPAAm and EC were dissolved in anhydrous ethanol under magnetic stirring for
12 h at room temperature, resulting in clear and homogenous solutions. The total
concentration of polymer was 25 % (w/v). KET was added into certain solutions at a
drug to polymer ratio of 1:4 (w/w). The viscosity of the electrospinning solutions was
measured using a viscometer (CAP 2000+, Brookfield Co. Ltd., USA). Full details of
the solutions prepared are listed in Table 1.
2.4 Electrospinning
The electrospinning solution was placed into a 5 mL plastic syringe fitted with a
stainless steel needle (internal diameter 0.5 mm), and the syringe was mounted on a
syringe pump (KDS100, Cole-Parmer, Vernon Hills, IL, USA). During spinning, the
flow rate of the solution was maintained at 0.5 mL / h. The needle was charged with a
positive voltage of 13 kV, provided by a high voltage power supply (ZGF-2000,
Shanghai Sute Electrical Co., Ltd., Shanghai, China). The working distance between
the needle tip and the grounded collector was fixed at 10 cm. The resultant fibers were
collected on a flat plate coated with aluminum foil, and subsequently dried at 25 ºC in
a vacuum oven (DZF-6050, Shanghai Laboratory Instrument Work Co. Ltd., Shanghai,
China) for 24 h to remove any residual solvent.
2.5 Characterization
The surface morphology of the fibers was analyzed with scanning electron
microscopy (SEM; JSM-5600 LV microscope, JEOL, Tokyo, Japan). Samples were
gold sputter-coated for 60 s under argon to render them electrically conductive prior
to visualization. The average fiber diameter for each sample was calculated by
measuring approximately 50 fibers in SEM images using the ImageJ software
(National Institutes of Health, Bethesda, MD, USA). Selected nanofibers were also
investigated using a transmission electron microscope (TEM, H-800 instrument,
Hitachi, Tokyo, Japan). The accelerating voltage during TEM experiments was 200
kV.
X-ray diffraction (XRD) was undertaken on a D/Max-BR diffractometer (Rigaku,
Tokyo, Japan) with Cu Kα radiation (40 kV / 20 mA) over the 2θ range 5 to 60°. 
Fourier transform infrared (FTIR) analysis was carried out on a Nicolet-Nexus 670
spectrometer (Nicolet Instrument Corporation, Madison, WI, USA) over the range
4000 – 500 cm-1 and with a resolution of 2 cm-1. Samples were prepared using the
KBr disk method (2 mg sample in 200 mg KBr).
The water contact angle (CA) was determined on a contact angle analyzer (DSA
30, Krüss GmbH, Hamburg, Germany) in air. A water droplet (ca. 2 µL) was placed
onto the surface of the fibers and the CA recorded. The measurement temperature was
controlled using a heating platform (XMTD-204, JTHF Company, Jintan, China).
Five measurements were recorded for each sample, and the results are reported as
mean ± S.D.
2.6 Molecular modelling
Molecular mechanics calculations were undertaken using HyperChem version 8.0.10.
The structures of each of the compounds were first drawn using ChemBio Draw Ultra
14.0. A decameric EC or PNIPAAm species was constructed to represent the polymer.
The individual structures were then imported into HyperChem, and models
constructed as detailed in previous work. Combinations of the energy minimised
polymer-KET structures were then merged to create drug-polymer complexes, and
these were subjected to the same minimisation procedures to determine whether they
were energetically stabilised in relation to the individual components. This procedure
is similar to that previously reported by Dott et al.36
2.7 In vitro drug release
For in vitro drug release studies, 80 mg of each sample was immersed in a plastic
bottle filled with 20 mL of phosphate buffer solution (PBS, pH 7.4) containing 0.05 %
v/v Tween-80 to enhance the solubility of KET. The bottle was incubated in a shaker
bath at two different temperatures (25 or 37 ºC) at a shaking rate of 90 rpm. At
predetermined time points, 1.4 mL of the PBS solution was removed to quantify the
drug concentration, and 1.4 mL of fresh buffer solution added to maintain the total
solution volume. The concentration of KET was measured using a UV-vis
spectrometer (UV-1800, SHJH Company, Shanghai, China) at a wavelength of 265
nm, following construction of an appropriate calibration curve. All the release studies
were performed in triplicate, and the results are given as mean ± S.D.
2.8 Cell viability experiments
Nanofibers were collected directly onto coverslips by electrospinning. 36 coverslips
were placed on the collector and electrospinning performed as detailed in Section 2.4,
for 4h. The coated slides were placed in 24-well plates (1 slide per well), with
untreated slides used as negative controls. The loaded plates were disinfected with
ultraviolet irradiation for 24 h.
L929 fibroblasts cells were cultured in DMEM medium supplemented with
penicillin (100 units / mL), streptomycin (100 µg / mL), and 10 % (v/v)
heat-inactivated fetal bovine serum. Trypsinization was used to detach the cells from
the culture flask, and 200 µL of dissociated L929 cells were seeded into the sterilized
24-well plates at a density of 4×103 cells per well. After 1, 3 or 5 days incubation (37
ºC, 5 % CO2), the culture medium in each well was removed and replaced with 360
μL of fresh DMEM and 40 μL of MTT solution (5 mg / mL thiazolyl blue in PBS). 
Following incubation for 4 h (37 ºC, 5 % CO2), the medium was removed and 400 μL 
of DMSO added to each well, after which the plates were shaken for 20 min at 37 ºC.
The solution from each well was transferred into a 96-well plate, and then the
absorbance measured at a wavelength of 570 nm using a microplate reader (Multiskan
FC, Thermo Scientific Instrument Co. Ltd., Shanghai, China). Three independent
MTT assays were carried out, with 6 replicates per assay.
3. Results and discussion
3.1 Morphology analysis
Scanning electron microscopy (SEM) images of the fibers are shown in Fig. 1. The
viscosities of the electrospinning solutions are listed in Table 1. F1, F2, F4, and F5
exhibit some flat ribbon-like fibers, with this being particularly evident for F1 and F4
where PNIPAAm is the sole polymer present and solution viscosity is low (less than
200 cP). Some beads are also observed on the surface of F2 and F5. These fibers are
formed from EC solutions for which the viscosity is very high (more than 300 cP).
Combining EC and PNIPAAm results in highly uniform fibers (F3), with no beads
visible and no ribbon-like fibers. Similarly regular cylindrical fibers are observed
when KET is introduced to the polymer blend (F6, F7, F8). Combining EC and
PNIPAAm thus appears to aid the formation of smooth fibers. The addition of EC to
the PNIPAAm solution results in higher viscosity which increases the
electrospinnability and aids the formation of smooth fibers.37 When the viscosity is
too high (as is the case with the pure EC solutions), beaded fibers (F2, F5) form
because the solution becomes difficult to force through the syringe
needle, making the solution flow rate somewhat unstable.38, 39 The ideal
viscosity for this system appears to lie between 200 cP and 300 cP.
Transmission electron microscopy (TEM) images of F3 and F6 are also given in
Fig. 1. As would be expected for the products of a single-fluid electrospinning process,
the fibers are monolithic in nature, with no evidence of any phase segregation. Both
the SEM and TEM images indicate that drug particles do not separate from the drug
loaded fibers during solvent evaporation.
The diameters of the fibers are given in Table 1. The diameters of the drug
loaded nanofibers (F4, F5, F6) are larger than those which consist of polymer alone
(F1, F2, F3). The F3, F6, F7 and F8 materials are more uniform in their diameters
than the other systems. The fibers containing only EC as the filament forming
polymer (F2, F5) are narrower than those made of PNIPAAm (F1, F4), with the blend
fibers (F3, F6, F7, F8) being intermediate in size.
3.2 Physical form analysis and component compatibility
X-ray diffraction patterns are given in Fig. 2A. Pure KET shows well-defined Bragg
reflections at 6.4°, 13.2°, 14.5°, 18.4°, 20.1°, 21.8°, 22.9°, 23.9°, 26.1° and 29.6° 2θ,
demonstrating its crystalline nature. PNIPAAm (F1) displays two broad diffuse
features centered at around 8° and 21°, consistent with its well-known amorphous
physical form.31 EC (F2) also displays two broad diffuse peaks, again indicating an
amorphous state.40 The pattern of F3 demonstrates that, as would be expected, the
blend fibers are also amorphous. The KET-loaded materials F4, F5 and F6
additionally show no Bragg reflections, which demonstrates that the drug has been
converted to the amorphous physical form by electrospinning.
The FTIR spectra of KET and the fibers are presented in Fig. 2B. F1 (PNIPAAm
fibers) shows a broad band between ca. 3700 and 3100 cm-1, which comprises a
superposition of H-bonded N-H stretches (3296 cm-1) as well as Amide I and II
combinations and overtone bands.41 It also has a series of absorptions at 2750 – 3000
cm-1 arising from CH3, CH2 and CH stretches, and distinct peaks at 1645 cm-1 (C=O
stretching vibration) and 1548 cm-1 (C-N stretching and N-H bending vibrations).
Vibrations at lower wavenumbers correspond to CH3, CH2 and CH bends. F2 (EC
alone) shows characteristic peaks at 3476 cm-1 (OH group vibrations), 2750 – 3000
cm-1 (CH3, CH2 and CH stretches) and 1109 cm-1 C-O-C stretching).42 Very similar
absorptions are present in F3, the blend fibers. However, there are some small shifts in
peak positions (e.g. from 3296 cm-1 in F1 to 3307 cm-1 in F3, and from 1645 cm-1 in
F1 to 1654 cm-1 in F3), which indicate the presence of intermolecular bonding
interactions between the two polymer components.
Considering the drug-loaded fibers, the major peaks from the polymers are again
visible, also with small red shifts from e.g. 3296 cm-1 in F1 to 3295 cm-1 in F4, from
1548 cm-1 in F1 to 1545 cm-1 in F4; or from 1109 cm-1 in F2 to 1107 cm-1 in F5. The
OH absorbances at 3466 cm-1 in F5 and F6 are also red shifted compared with pure
EC (F2), where this stretch is located at 3476 cm-1.
The FTIR spectrum for pure ketoprofen shows two distinct peaks: one at 1696
cm-1 representing the stretching vibration of the carbonyl group in the KET dimer, and
another at 1655 cm-1 from stretching of the ketone group. The peak at 1696 cm-1 is
observed because in its crystalline form KET molecules are bound together in dimers
through intermolecular hydrogen bonds. The peak at 1655 cm-1 is present in the
spectra of F4, F5 and F6, which indicates the presence of KET in these samples. It is
however shifted somewhat: in F4, this peak is merged with the PNIPAAm C=O
stretch into a single peak at 1645 cm-1, and in F5 is moved to 1658 cm-1. The peak at
1696 cm-1 cannot be seen in the spectra of F4, F5 and F6, indicating the absence of
any KET dimers in the fibers. This is consistent with the result of X-ray diffraction
analysis, which showed the absence of any crystalline (dimeric) KET.
3.3 Molecular modelling
Since KET has C=O groups, EC has -OH groups, and PNIPAAm has NH groups, it is
to be expected that there will be H-bonding interactions between KET and EC or KET
and PNIPAAm.37 The shifts in peak positions identified in the IR spectra indicated
that such interactions do indeed occur in the fibers; to confirm this, we constructed
some simple molecular models of EC, PNIPAAm and KET using the HyperChem
software. The structures of an EC or PNIPAAM decamer and KET were first
individually optimized, and subsequently appropriate combinations of the
energetically minimized structures were merged to create drug-polymer complexes.
The geometric preferences for the energetically minimized EC-PNIPAAm and
KET-polymer complexes are depicted in Fig. 3. The energetic contributions to the
overall steric energies are listed in Table 2.
It is clear from the data in Table 2 that, as was indicated from the IR spectra,
there are a number of intermolecular interactions (both van der Waals and H-bonding)
between the drug and polymers, as well as between PNIPAAm and EC. Stabilisation
of the complexes is indicated by a negative difference between the total steric energy
of the complex and the sum of the energies of the individual molecules (∆E = Ecomplex
– Ecomponents). The combined steric energy of PNIPAAm and KET is 15.974 kcal /
mol, whereas that of the complex is 0.315 kcal mol-1. This gives a ∆E of - 15.659 kcal 
/ mol. For EC-KET ∆E = -17.021 kcal / mol, and for PNIPAAm-EC ∆E = -9.557 kcal 
/ mol. Thus, in all cases there are favorable stabilizing interactions between the
components of the system; these comprise both van der Waals and H-bonding
interactions.
3.4 Thermoresponsive behavior
The wettability of the nanofibers was studied as a function of temperature, and the
results are depicted in Fig. 4A. The water contact angles of the drug-free and
analogous drug-loaded nanofibers are basically identical (F1 cf. F4; F2 cf. F5; F3 cf.
F6). The addition of KET thus has little influence on the contact angles. The pure EC
fibers are hydrophobic regardless of the temperature, with only a very small increase
in contact angle seen across the temperature range studied. In contrast, as the
temperature is raised from 25 ºC to 45 ºC, the surfaces of the PNIPAAm-containing
fibers change abruptly from being hydrophilic to hydrophobic. This occurs as the
temperature increases through the LCST between 31 ºC and 33 ºC, and results in a
dramatic increase in the contact angle.
Fig. 4B shows the proposed mechanism underlying the thermoresponsive
properties of the PNIPAAm/EC composite nanofibers. When the temperature is below
the LCST (32 ºC), the hydrophilic C=O and N-H groups in the PNIPAAm chains
interact easily with water molecules to form intermolecular hydrogen
bonds.43Although there are hydrophobic EC molecules also present in the blend fibers,
the water droplets can presumably minimize their contact with these and maximize
their interactions with PNIPAAm units. Consequently, the blend fibers exhibit
hydrophilic properties below the PNIPAAm LCST. When the temperature is above the
LCST, the formation of intramolecular hydrogen bonds between the C=O and N-H
groups in PNIPAAm lead to a collapsed globular conformation of the chains, which
makes it very hard for their C=O and N-H groups to interact with water molecules.29
Therefore, the blend fibers are hydrophobic above the LCST.
3.5 Drug release
In vitro KET release profiles of KET from the drug loaded nanofibers are given in Fig.
5. Considering first the data in Fig. 5A (1:2 PNIPAAm/EC systems), at 25 ºC, the
amount of drug release from F4 (PNIPAAm) is highest, followed by F7
(PNIPAAm/EC 1:2 w/w) and F5 (EC). The different drug release profiles may be
explained by the fibers’ different surface wettability. Drug release from a hydrophilic
carrier tends to be faster than that from a hydrophobic material.30 When the
temperature is 25 ºC, the PNIPAAm-containing fibers exhibit hydrophilic properties,
while the EC materials are hydrophobic. The fibers comprising only PNIPAAm as the
filament-forming polymer are more hydrophilic than the blend fibers, explaining why
the latter lies intermediate between the two extremes. At 37 ºC, there is a burst release
of roughly 40% of the loaded drug in the first 5 h of the dissolution experiment. Very
little further release is seen from F4, while F5 and F6 show slow, sustained, release
over ca. 55 h. F6 releases most drug under these conditions, followed by F5 and F4.
The drug release profile from the EC fibers (F5) is very similar at both
temperatures investigated. This is because EC is not thermoresponsive, but can be
used as a sustained-release drug delivery system. In contrast, the maximum drug
release from the PNIPAAm-containing fibers is much greater at 25 ºC than at 37 ºC,
as a result of the temperature sensitive properties of PNIPAAm. However, at both
temperatures the F4 fibers show a very significant burst release at the start of the
experiment. These effects are somewhat reduced for the PNIPAAm/EC F6 samples,
indicating that the blend nanofibers combine the advantages of the two polymers,
possessing both thermosensitive and sustained release properties. These results thus
demonstrate the concept of using PNIPAAm/EC blend fibers for
temperature-triggered sustained release.
The influence of the PNIPAAm/EC weight ratios was also explored, and a
comparison of F6, F7 and F8 are presented in Fig. 5B. At 25 ºC, the amount of drug
released from F7 (PNIPAAm/EC 1:1) is highest, followed by F6 (1:2) and F8 (1:4). At
37 ºC, the opposite trend is seen. These observations indicate that an increased content
of EC decreases the drug release rate at 25ºC but increases it at 37ºC. This is to be
expected, since PNIPAAm becomes hydrophobic at T > 32 ºC but is hydrophilic
below this temperature. Thus, at 25 ºC the hydrophilic nature of the PNIPAAm
increases the rate of release, and F7 (which contains most PNIPAAm) releases its
KET load most rapidly. At 37 ºC, the hydrophobic nature of the PNIPAAm delays
release; thus, the more PNIPAAm present the slower the drug release rate, and F7
releases most slowly under these conditions. The drug release profiles from F8
(PNIPAAm/EC 1:4) are similar at both temperatures investigated; the low PNIPAAm
content in this system is presumably insufficient to provide it with significant
thermoresponsive properties.
3.6 Cell viability
The results of MTT cell viability measurements performed on the fibers are given in
Fig. 6. As expected, the number of cells present increased from day 1 to day 5 in all
cases. The cell viability of analogous drug-free fibers and drug-loaded fibers are
almost identical. Compared to the negative control (blank coverslips), there is a
noticeable reduction in cell growth with F1 and F4. There is also possibly a much
smaller decrease with F3 and F6, and a small increase in cell number with F2 and F5.
From these observations, it can be inferred that the surfaces of EC nanofibers are
more suitable for cell growth than those of PNIPAAm. As a result, the cell number
observed with F3 (F6) is intermediate between F1 (F4) and F2 (F5). Overall however,
the viability of cells grown on the PNIPAAm/EC fibers is high, which is very
promising for potential biomedical applications.
4. Conclusions
Nanoscale fibers made of poly(N-isopropylacrylamide) (PNIPAAm), ethyl cellulose
(EC) and blends of the two were prepared by electrospinning. Ketoprofen (KET) was
selected as a model drug, and analogous drug-loaded fibers also generated. The blend
fibers have more regular morphologies than the single-polymer materials. X-ray
diffraction data demonstrate that KET exists in the amorphous physical form in the
drug-loaded fibers. There are significant intermolecular interactions between KET and
the polymers, as evidenced by IR spectroscopy and molecular modelling. The water
contact angle of the PNIPAAm and blend nanofibers changes abruptly upon heating,
increasing from 45 ± 2.5º to 124 ± 4º for the latter when the temperature is increased
through the lower critical solution temperature of 32 ºC. The fibers thus undergo a
rapid hydrophilic/hydrophobic transition at this point. With a 1:2 weight ratio of
PNIPAAm/EC in the fibers, KET release at 25 ºC is much faster than at 37 ºC as a
result of this dramatic change in properties. The same results are observed with a 1:1
ratio, but the release rate from the fibers is rather low at 37 ºC. When the
PNIPAAm/EC ratio is raised to 1:4 the materials appear to lose most of their
thermoresponsive properties. The blend fibers also proved to be non-toxic and
suitable for cell growth. This study thus demonstrates that electrospun blend
PNIPAAm/EC fibers can be used as thermoresponsive carriers for the sustained
release of poorly water soluble drugs, as well as in tissue engineering.
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Fig. 1. SEM images of the fibers produced in this work, together with TEM images of
F3 and F6. The scale bar at the bottom of all the SEM images corresponds to 10 µm.
Fig. 2. A) XRD patterns and B) FTIR spectra of KET and selected fibers.
Fig. 3. The optimized geometric arrangements of A) PNIPAAm-KET, B) EC-KET,
and C) PNIPAAm-EC. In A) and B), the polymer is at the top of the image and the
drug molecule at the bottom; in C), EC is at the top and PNIPAAm at the bottom.
Fig. 4. A) The temperature dependence of the fibers’ water contact angles and B) the
proposed mechanism underlying the thermoresponsive properties of the
PNIPAAm-containing fibers.
Fig. 5. In vitro KET release profiles from the electrospun fibers. The drug-loaded
PNIPAAm (F4), EC (F5), and 1:2 blend (F6) materials are shown in A), while B)
depicts the effect of changing the PNIPAAm: EC ratio from 1:2 (F6) to 1:1 (F7) and
1:4 (F8).
Fig. 6. The viability of L929 cells grown on blank coverslips and those coated with
the fibers.
Table 1. Details of the spinning solutions used in this study.
ID Solution
content
PNIPAAm
to EC
ratio
(w/w)
Total
polymer
conc.
(% w/v)
Drug
conc.
(% w/v)
Mean
diameter ±
SD (nm)
Viscosity
(cP)
F1 PNIPAAm 1:0 25 ---- 638 ± 157 68.4 ± 11.5
F2 EC 0:1 25 ---- 343 ± 110 309.2 ± 10.6
F3 PNIPAAm/
EC
1:2 25 ---- 400 ± 56 235.6 ± 12.2
F4 PNIPAAm/
KET
1:0 25 6.25 679 ± 191 92.3 ± 11.9
F5 EC/KET 0:1 25 6.25 415 ± 142 317.2 ± 11.2
F6 PNIPAAm/
EC/KET
1:2 25 6.25 513 ± 72 242.4 ± 13.4
F7 PNIPAAm/
EC/KET
1:1 25 6.25 532 ± 78 208.1 ± 13.7
F8 PNIPAAm/
EC/KET
1:4 25 6.25 392 ± 63 286.5 ± 14.4
Table 2. Energetic values for the optimized KET, polymer, and KET-polymer
complexes. The electrostatic contribution was found to be zero in all cases.
Species
Minimized energy combinations (kcal / mol)
Bond
stretching
Bond
angle
Torsional
Vander
Waals
Hydrogen
bonding
Total
KET 0.692 1.132 5.485 6.808 0.000 14.116
PNIPAAm 1.750 6.116 1.346 -7.336 -0.018 1.858
EC 6.752 48.182 101.722 -8.072 -0.539 148.045
PNIPAAm-KET 2.555 7.874 7.015 -16.826 -0.302 0.315
EC-KET 7.319 50.005 107.765 -19.409 -0.540 145.140
PNIPAAm-EC 8.463 55.851 108.998 -32.378 -0.587 140.346
